Jagsonpal Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals has submitted a quarterly compliance certificate to BSE and NSE as required under SEBI's Depositories Regulations. The certificate was issued by MCS Share Transfer Agent Limited, the company's Registrar and Share Transfer Agent, for the quarter ended June 30, 2025. It confirms that physical share certificates received for dematerialization were listed on the stock exchanges within 15 days, and that the original certificates were cancelled after verification with the depository recorded as the new registered owner. The filing was made on July 7, 2025, signed by the Company Secretary Pratham Rawal.
This is a routine quarterly regulatory compliance filing with no material impact on the company's financials, operations, or stock price. It merely confirms proper handling of dematerialization requests during the April–June 2025 quarter.